CIK 827871

EAGLE PHARMACEUTICALS, INC.

EDGAR filings

Customers

0 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Dec 31, 2021

10-K filed 2022-03-08

Customers 6

Companies EAGLE PHARMACEUTICALS, INC. discloses as major customers, as a share of EAGLE PHARMACEUTICALS, INC. revenue. 0 active, 6 lapsed.

Company	% of EAGLE PHARMACEUTICALS, INC. revenue	Est. revenue	Period	Trend	Status	Source
Cephalon, Inc. Non-SEC Cephalon, Inc.	66%	$113.2M	FY 2021-12-31	−1.0pp	Lapsed Last seen 2021-12-31	10-K 2022-03-08
Cephalon, Inc. (Teva) - See Revenue Recognition 66 % 67 % 77 % 10-K filed 2022-03-08 Period FY 2021-01-01 to 2021-12-31 (66%), FY 2020-01-01 to 2020-12-31 (67%), FY 2019-01-01 to 2019-12-31 (77%)Accession 0000827871-22-000008 Cephalon, Inc. (Teva) - See Revenue Recognition 66 % 65 % 10-Q filed 2021-05-10 Period 3M 2021-01-01 to 2021-03-31 (66%), 3M 2020-01-01 to 2020-03-31 (65%)Accession 0000827871-21-000016 Cephalon, Inc. (Teva) - See Revenue Recognition 74 % 85 % 72 % 78 % 10-Q filed 2020-11-02 Period 3M 2020-07-01 to 2020-09-30 (74%), 3M 2019-07-01 to 2019-09-30 (85%)Accession 0000827871-20-000028 Cephalon, Inc. (Teva) - See Revenue Recognition 78 % 67 % 71 % 75 % 10-Q filed 2020-08-10 Period 3M 2020-04-01 to 2020-06-30 (78%), 3M 2019-04-01 to 2019-06-30 (67%)Accession 0000827871-20-000024 Cephalon, Inc. (Teva) - See Revenue Recognition 65 % 84 % 10-Q filed 2020-05-11 Period 3M 2019-01-01 to 2019-03-31 (84%)Accession 0000827871-20-000014 Cephalon, Inc. (Teva) - See Revenue Recognition 67 % 77 % 75 % 10-K filed 2021-03-05 Period FY 2018-01-01 to 2018-12-31 (75%)Accession 0000827871-21-000011 Cephalon, Inc. (Teva) - See Revenue Recognition 85 % 74 % 78 % 75 % 10-Q filed 2019-11-12 Period 3M 2018-07-01 to 2018-09-30 (74%)Accession 0000827871-19-000026 Cephalon, Inc. (Teva) - See Revenue Recognition 67 % 70 % 75 % 76 % 10-Q filed 2019-08-08 Period 3M 2018-04-01 to 2018-06-30 (70%)Accession 0000827871-19-000020 Cephalon, Inc. (Teva) - See Revenue Recognition 84 % 84 % 10-Q filed 2019-05-07 Period 3M 2018-01-01 to 2018-03-31 (84%)Accession 0000827871-19-000013 Cephalon, Inc. (Teva) - See Revenue Recognition 77 % 75 % 79 % 10-K filed 2020-03-02 Period FY 2017-01-01 to 2017-12-31 (79%)Accession 0000827871-20-000007 Cephalon, Inc. (Teva) - See Revenue Recognition 74 % 67 % 75 % 78 % 10-Q filed 2018-11-01 Period 3M 2017-07-01 to 2017-09-30 (67%)Accession 0000827871-18-000010 Cephalon, Inc. (Teva) - See Revenue Recognition 70 % 77 % 76 % 83 % 10-Q filed 2018-08-07 Period 3M 2017-04-01 to 2017-06-30 (77%)Accession 0000827871-18-000008 Cephalon, Inc. (Teva) - See Revenue Recognition 84 % 87 % 10-Q filed 2018-05-10 Period 3M 2017-01-01 to 2017-03-31 (87%)Accession 0000827871-18-000005 Cephalon, Inc. (Teva) - See Revenue Recognition 75 % 79 % 79 % 10-K filed 2019-02-28 Period FY 2016-01-01 to 2016-12-31 (79%)Accession 0000827871-19-000008 Cephalon, Inc. (Teva) - See Revenue Recognition 67 % 77 % 78 % 72 % 10-Q filed 2017-11-08 Period 3M 2016-07-01 to 2016-09-30 (77%)Accession 0000827871-17-000010 Cephalon, Inc. (Teva) - See Revenue Recognition 77 % 80 % 83 % 71 % 10-Q filed 2017-08-09 Period 3M 2016-04-01 to 2016-06-30 (80%)Accession 0000827871-17-000007 Cephalon, Inc. (Teva) - See Revenue Recognition 87 % 61 % 10-Q filed 2017-05-08 Period 3M 2016-01-01 to 2016-03-31 (61%)Accession 0000827871-17-000004
Par Pharmaceuticals Companies, Inc. Non-SEC Par Pharmaceuticals Companies, Inc.	20%	$5.9M	3M 2016-03-31		Lapsed Last seen 2016-03-31	10-Q 2016-05-10
Par Pharmaceuticals Companies, Inc. - See Note 11 20 % — % 10-Q filed 2016-05-10 Period 3M 2016-01-01 to 2016-03-31 (20%)Accession 0000827871-16-000064
SymBio Pharmaceuticals Limited Non-SEC SymBio Pharmaceuticals Limited	20%	$12.6M	3M 2017-09-30		Lapsed Last seen 2017-09-30	10-Q 2018-11-01
SymBio Pharmaceuticals Limited — % 20 % — % 7 % 10-Q filed 2018-11-01 Period 3M 2017-07-01 to 2017-09-30 (20%)Accession 0000827871-18-000010
CAH Distributor CARDINAL HEALTH INC	10%	$5.1M	3M 2018-09-30	+8.0pp	Lapsed Last seen 2018-09-30	10-Q 2018-11-01
Cardinal Health 10 % 2 % 6 % 2 % 10-Q filed 2018-11-01 Period 3M 2018-07-01 to 2018-09-30 (10%), 3M 2017-07-01 to 2017-09-30 (2%)Accession 0000827871-18-000010
Sandoz, Inc. Non-SEC Sandoz, Inc.	6%	$3.0M	3M 2017-06-30	+5.0pp	Lapsed Last seen 2017-06-30	10-Q 2017-08-09
Sandoz, Inc. 6 % 5 % 4 % 4 % 10-Q filed 2017-08-09 Period 3M 2017-04-01 to 2017-06-30 (6%), 3M 2016-04-01 to 2016-06-30 (5%)Accession 0000827871-17-000007 Sandoz, Inc. 1 % 2 % 10-Q filed 2017-05-08 Period 3M 2017-01-01 to 2017-03-31 (1%), 3M 2016-01-01 to 2016-03-31 (2%)Accession 0000827871-17-000004 Sandoz, Inc. 5 % 5 % 55 % 53 % 10-K filed 2017-03-15 Period FY 2016-01-01 to 2016-12-31 (5%)Accession 0000827871-17-000002 Sandoz, Inc. 7 % 28 % 5 % 10 % 10-Q filed 2016-11-09 Period 3M 2016-07-01 to 2016-09-30 (7%), 3M 2015-07-01 to 2015-09-30 (28%)Accession 0000827871-16-000080 Sandoz, Inc. 5 % 30 % 4 % 7 % 10-Q filed 2016-08-09 Period 3M 2015-04-01 to 2015-06-30 (30%)Accession 0000827871-16-000074 Sandoz, Inc. 28 % 42 % 10 % 45 % 10-Q filed 2015-11-12 Period 3M 2014-07-01 to 2014-09-30 (42%)Accession 0000827871-15-000047 Sandoz, Inc. 30 % 27 % 7 % 45 % 10-Q filed 2015-08-11 Period 3M 2014-04-01 to 2014-06-30 (27%)Accession 0000827871-15-000042
The Medicines Company Non-SEC The Medicines Company	2%	$4.7M	FY 2017-12-31	−2.0pp	Lapsed Last seen 2017-12-31	10-K 2018-02-26
The Medicines Company /Chiesi USA, Inc. 2 % 4 % 14 % 10-K filed 2018-02-26 Period FY 2017-01-01 to 2017-12-31 (2%), FY 2016-01-01 to 2016-12-31 (4%)Accession 0000827871-18-000003 Chiesi USA, Inc. / The Medicines Company 3 % 4 % 3 % 5 % 10-Q filed 2017-08-09 Period 3M 2017-04-01 to 2017-06-30 (3%), 3M 2016-04-01 to 2016-06-30 (4%)Accession 0000827871-17-000007 The Medicines Company/Chiesi USA, Inc. 4 % 6 % 10-Q filed 2017-05-08 Period 3M 2017-01-01 to 2017-03-31 (4%), 3M 2016-01-01 to 2016-03-31 (6%)Accession 0000827871-17-000004 The Medicines Company/Chiesi USA, Inc. 5 % 37 % 6 % 15 % 10-Q filed 2016-11-09 Period 3M 2016-07-01 to 2016-09-30 (5%), 3M 2015-07-01 to 2015-09-30 (37%)Accession 0000827871-16-000080 The Medicines Company 4 % 37 % 5 % 13 % 10-Q filed 2016-08-09 Period 3M 2015-04-01 to 2015-06-30 (37%)Accession 0000827871-16-000074 The Medicines Company 37 % 50 % 15 % 26 % 10-Q filed 2015-11-12 Period 3M 2014-07-01 to 2014-09-30 (50%)Accession 0000827871-15-000047 The Medicines Company 37 % 13 % 13 % 20 % 10-Q filed 2015-08-11 Period 3M 2014-04-01 to 2014-06-30 (13%)Accession 0000827871-15-000042

Alerts are coming

Get an email when EAGLE PHARMACEUTICALS, INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.